AstraZeneca demonstrates commitment to predictive science at international modelling conference
The 2011 American Conference of Pharmacometrics (ACOP) got underway this weekend with attendees from...
Oncodesign offers world’s most comprehensive collection of patient-derived colorectal tumor models
Oncodesign announced today that the company has acquired exclusive commercialization rights to distribute the world’s...
CIT launches LeadScreen (TM), a new range of fast, cost-effective services for drug candidate...
CIT, a leading European non-clinical CRO specialized in health and safety research, announces today a...
Ken Jones, COO Europe, Astellas joins GSK, Shire, Takeda and Bausch & Lomb on...
With one week to go SFE Europe shows no sign of slowing down. With over...
Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor in advanced basal...
Roche announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor,...
Novartis completes acquisition of majority stake in Zhejiang Tianyuan
Novartis announced that it completed the transaction to acquire an 85 percent stake in the...
Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall...
Bristol-Myers Squibb Company announced that a clinical trial -- known as study 024 -- of...
PharmaDiagnostics announces three new coupling methods for its SoPRano(TM) label-free platform
PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does...
Provepharm receives favorable EMA Review of its methylthioninium chloride Proveblue
Provepharm, a start-up specialized in the development of pharmaceutical applications, announces today that, following a...
TxCell names François Meyer as CEO
TxCell SA, a biotechnology company developing cell-based immuno-therapies for the treatment of severe chronic inflammatory...
